We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+40.4%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.91B
AUM Growth
+$392M
Cap. Flow
+$18.5M
Cap. Flow %
0.96%
Top 10 Hldgs %
43.56%
Holding
164
New
31
Increased
23
Reduced
65
Closed
25

Sector Composition

Rank Sector Weight
1 Healthcare 22.53%
2 Financials 7.81%
3 Consumer Discretionary 7.09%
4 Industrials 4.45%
5 Technology 3.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRPT icon
26
Sarepta Therapeutics
SRPT
$1.68B
$19.1M 1%
990,000
+315,000
+47% +$5.62M
HIMS icon
27
PUT
Hims & Hers Health
HIMS
$7.13B
$17.6M 0.92%
310,000
LLY icon
28
Eli Lilly
LLY
$1,000B
$17.4M 0.91%
22,750
+5,000
+28% +$3.72M
ANAB icon
29
AnaptysBio
ANAB
$1.59B
$16.7M 0.88%
547,000
+47,000
+9% +$1.08M
UNH icon
30
UnitedHealth
UNH
$377B
$16.6M 0.87%
48,000
-7,500
-14% -$2.27M
COF icon
31
PUT
Capital One
COF
$134B
$15.9M 0.83%
75,000
BBIO icon
32
BridgeBio Pharma
BBIO
$15.7B
$15.6M 0.81%
300,000
-125,000
-29% -$6.1M
MOH icon
33
Molina Healthcare
MOH
$10.2B
$15.5M 0.81%
+81,000
New +$14.9M
LEN.B icon
34
Lennar Class B
LEN.B
$20.1B
$13.8M 0.72%
115,000
GOSS icon
35
Gossamer Bio
GOSS
$84.9M
$13.3M 0.7%
5,059,200
-1,280,800
-20% -$2.82M
KNOP icon
36
KNOT Offshore Partners
KNOP
$370M
$12.9M 0.67%
1,460,402
-124,598
-8% -$954K
IONQ icon
37
PUT
IonQ
IONQ
$14.5B
$12.6M 0.66%
205,000
+50,000
+32% +$2.35M
ERO icon
38
Ero Copper
ERO
$2.85B
$12.1M 0.63%
600,000
-450,000
-43% -$6.85M
SNDK
39
Sandisk
SNDK
$191B
$11.9M 0.62%
106,000
-26,000
-20% -$1.52M
TGTX icon
40
TG Therapeutics
TGTX
$7.07B
$11.7M 0.61%
+325,000
New +$10.7M
IAG icon
41
IAMGOLD
IAG
$8.53B
$11.6M 0.61%
900,000
+390,000
+76% +$3.42M
ASML icon
42
ASML
ASML
$631B
$10.6M 0.56%
11,000
-3,650
-25% -$2.87M
INSE icon
43
Inspired Entertainment
INSE
$183M
$10.6M 0.55%
1,125,000
-240,000
-18% -$2.16M
MEDP icon
44
PUT
Medpace
MEDP
$16B
$10.3M 0.54%
+20,000
New +$8.73M
MREO
45
Mereo BioPharma
MREO
$50.4M
$10M 0.52%
4,875,000
+525,000
+12% +$968K
LEN icon
46
Lennar Class A
LEN
$20.5B
$9.96M 0.52%
79,000
ZVRA icon
47
Zevra Therapeutics
ZVRA
$594M
$9.27M 0.48%
975,000
-150,000
-13% -$1.5M
XHR
48
Xenia Hotels & Resorts
XHR
$1.89B
$8.85M 0.46%
645,000
-245,000
-28% -$3.33M
ARIS
49
Aris Mining
ARIS
$2.97B
$8.82M 0.46%
900,000
-600,000
-40% -$4.78M
GOOGL icon
50
Alphabet (Google) Class A
GOOGL
$4.57T
$8.75M 0.46%
36,000

Similar funds

683 Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, 683 Capital Management held 164 positions worth $1.91B, up 26% from $1.52B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

683 Capital Management's Q3 2025 filing shows 31 new, 23 increased, 65 reduced and 25 closed positions. Its largest new stake was Molina Healthcare: 81,000 shares worth $15.5M. The largest sale was Barrick Mining, an estimated $15.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

  • 683 Capital Management's largest Q3 2025 buy was Molina Healthcare: 81,000 shares worth $15.5M.
  • 683 Capital Management added most to Cogent Communications in Q3 2025, an estimated $15.4M increase.
  • 683 Capital Management's biggest Q3 2025 reduction was Barrick Mining, cutting an estimated $15.8M.
  • 683 Capital Management fully exited Sage Therapeutics in Q3 2025, selling an estimated $10.5M.
  • 683 Capital Management's ten largest holdings make up 44% of its $1.91B portfolio in Q3 2025.
  • 683 Capital Management opened 31 new positions and closed 25 in Q3 2025.
  • 683 Capital Management's portfolio value rose 26% quarter-over-quarter to $1.91B.

Based on 683 Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.